Director, Global Value & Access (Cell Therapy) – Hybrid

Gilead Sciences Inc.; El Segundo (CA); Hybrid; USD 206,000 - 266,000; Full time

Job summary

Kite Pharma seeks a Director, Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune to lead global market access strategies across the product lifecycle. You will partner with Global Clinical Development, HEOR/RWE, Medical Affairs, and Commercial teams to ensure payer perspectives inform development and launch plans.

You will drive evidence generation, pricing, and reimbursement strategies, while navigating diverse global markets and lifecycle management.

Qualifications

• 8+ years with a PhD/ PharmD
• 10+ years with MS/MA, MBA, PharmD, or equivalent advanced degree
• 12+ years with BS/BA
• Experience in autoimmune disease programs and market access
• Background in cell therapy or gene therapy is preferred
• Experience influencing cross-functional teams

Responsibilities

• Lead global market access strategies across product lifecycle
• Develop global value and access strategies for autoimmune programs
• Collaborate with HEOR, Clinical Development, Medical Affairs and Commercial teams
• Shape evidence generation plans for payer perspectives
• Provide strategic leadership on US market access dynamics

Skills

Market access leadership

HEOR/RWE collaboration

Strategic thinking

Cross-functional collaboration

Education

PhD/PharmD (8+ yrs)

MS/MA, MBA, PharmD, PhD (10+ yrs)

BS/BA (12+ yrs)

Job description

Kite Pharma seeks a Director, Global Value & Access Strategy (GVAS) for Cell-therapy Autoimmune to lead global market access strategies across the product lifecycle. You will partner with Global Clinical Development, HEOR/RWE, Medical Affairs, and Commercial teams to ensure payer perspectives inform development and launch plans.

You will drive evidence generation, pricing, and reimbursement strategies, while navigating diverse global markets and lifecycle management.